Providing Personalized Health and Individual Lifestyle Enhancing Solutions (Prophiles) in CVD
Providing Personalized Health and Individual Lifestyle Enhancing Solutions (Prophiles) in Cardiovascular Disease (CVD)
Sponsor: NYU Langone Health
This NA trial investigates Cardiovascular Diseases and is currently completed. NYU Langone Health leads this study, which shows 11 recorded versions since 2020 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2022 — Jul 2024 [monthly]
Completed NA
-
Nov 2021 — Jan 2022 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — Nov 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 6 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
-
Jun 2019 — Feb 2020 [monthly]
Not Yet Recruiting NA
-
Feb 2019 — Jun 2019 [monthly]
Not Yet Recruiting NA
-
Jan 2019 — Feb 2019 [monthly]
Not Yet Recruiting NA
-
Nov 2018 — Jan 2019 [monthly]
Not Yet Recruiting NA
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .